Cystic fibrosis laboratory findings: Difference between revisions
Jump to navigation
Jump to search
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
Immunoreactive trypsinogen (IRT) of serum is raised in newborns with cystic fibrosis and has been used as a screening test | |||
==Laboratory Findings== | ==Laboratory Findings== | ||
* | * Immunoreactive trypsinogen (IRT) of serum is raised in newborns with cystic fibrosis and has been used as a screening test.<ref name="pmid2704582">{{cite journal |vauthors=Rock MJ, Mischler EH, Farrell PM, Bruns WT, Hassemer DJ, Laessig RH |title=Immunoreactive trypsinogen screening for cystic fibrosis: characterization of infants with a false-positive screening test |journal=Pediatr. Pulmonol. |volume=6 |issue=1 |pages=42–8 |date= 1989 |pmid=2704582 |doi= |url=}}</ref> | ||
==References== | ==References== | ||
Revision as of 20:54, 23 February 2018
|
Cystic fibrosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cystic fibrosis laboratory findings On the Web |
|
American Roentgen Ray Society Images of Cystic fibrosis laboratory findings |
|
Risk calculators and risk factors for Cystic fibrosis laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shaghayegh Habibi, M.D.[2]
Overview
Immunoreactive trypsinogen (IRT) of serum is raised in newborns with cystic fibrosis and has been used as a screening test
Laboratory Findings
- Immunoreactive trypsinogen (IRT) of serum is raised in newborns with cystic fibrosis and has been used as a screening test.[1]